Journal ArticleOPEN ACCESS

Macrolide Resistance in MORDOR I — A Cluster-Randomized Trial in Niger

  • Doan T
  • Arzika A
  • Hinterwirth A
  • et al.
New England Journal of Medicine (2019) 380(23) 2271-2273
DOI: 10.1056/nejmc1901535
97Citations
Citations of this article
110Readers
Mendeley users who have this article in their library.

Abstract

Macrolide Antimicrobial Resistance in MORDOR I In MORDOR I, azithromycin decreased mortality in children in Niger. In this report, it is shown that azithromycin also increased antimicrobial resista...

Cite

CITATION STYLE

APA

Doan, T., Arzika, A. M., Hinterwirth, A., Maliki, R., Zhong, L., Cummings, S., … Lietman, T. M. (2019). Macrolide Resistance in MORDOR I — A Cluster-Randomized Trial in Niger. New England Journal of Medicine, 380(23), 2271–2273. https://doi.org/10.1056/nejmc1901535

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free